Vanguard Portfolio Management
BSX icon

Vanguard Portfolio Management’s Boston Scientific BSX Stock Holding History

Vanguard Portfolio Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27B Sell
29,792,794
-3,417
-0% -$186K 0.06% 379
2026
Q1 		$1.87B Buy
+29,796,211
New +$2.38B 0.1% 235

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Portfolio Management's BSX Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Boston Scientific (BSX) stake by 0.01% in Q2 2026, selling an estimated $186K and leaving 29,792,794 shares worth $1.27B. The position accounts for 0.06% of the portfolio, ranked #379.

Vanguard Portfolio Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.87B in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard Portfolio Management held 29,792,794 shares of Boston Scientific worth $1.27B as of Q2 2026.
  • Vanguard Portfolio Management sold 3,417 Boston Scientific shares in Q2 2026, an estimated $186K.
  • Boston Scientific made up 0.06% of Vanguard Portfolio Management's portfolio in Q2 2026, its #379 holding.
  • Vanguard Portfolio Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Boston Scientific position peaked at $1.87B in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.